Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure

Aim. To evaluate the long-term impact of endovascular left atrial appendage occlusion (LAAO) on heart failure (HF) course in patients with atrial fibrillation (AF).Materials and Methods: The prospective cohort study included patients with AF, HF, and a high risk of thromboembolic events, of which 39...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Pevzner, N. S. Kostritca, I. A. Merkulova, O. B. Dorogun, A. L. Komarov, I. S. Yavelov
Format: Article
Language:English
Published: Столичная издательская компания 2023-10-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2934
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227486657773568
author D. V. Pevzner
N. S. Kostritca
I. A. Merkulova
O. B. Dorogun
A. L. Komarov
I. S. Yavelov
author_facet D. V. Pevzner
N. S. Kostritca
I. A. Merkulova
O. B. Dorogun
A. L. Komarov
I. S. Yavelov
author_sort D. V. Pevzner
collection DOAJ
description Aim. To evaluate the long-term impact of endovascular left atrial appendage occlusion (LAAO) on heart failure (HF) course in patients with atrial fibrillation (AF).Materials and Methods: The prospective cohort study included patients with AF, HF, and a high risk of thromboembolic events, of which 39,6% underwent LAAO, 60,4% — received standard preventive therapy for cardioembolic events. Changes in BNP levels in the LAAO and control groups were analyzed throughout the observation period. The incidence of unfavorable HF outcomes (decompensated HF, hospitalizations related to HF, worsening HF class) was compared using the Cox-regression analysis with the log-rank test. A univariate analysis using Cox regression was conducted to identify independent predictors of endpoint achievement, involving all clinical and historical factors. Subsequently, a multivariate analysis was carried out, with predictors selected through the Wald exclusion test from those factors with a p-value less than 0.2 in the univariate analysis. Each factor was found to be a statistically significant independent predictor of the endpoint, with the overall model significance of p<0,001Results: s. The study included 139 patients (55 — LAAO group; 84 — control group) with a 3-year follow-up period. Most patients in the study had class I-III HF with preserved left ventricular ejection fraction (93,5%). In both groups, the level of BNP increased significantly over the observational period. Despite the initial differences between the groups, no differences were observed between the groups 1-3 years after the start of the study, which may indicate a tendency towards a lower growth rate of BNP in the LAAO group. The achievement rate of all endpoints was similar in both groups without significant differences. Multivariate analysis identified significant predictors of HF decompensation in the study cohort including left atrial volume, BNP levels, and HF class.Conclusion. Our study hasn’t shown any negative impact of endovascular LAAO on HF course in patients with AF. Additionally, several predictors of HF decompensation were identified in this patient cohort.
format Article
id doaj-art-3646812dbe1c40968faddbc02b4c8d7e
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2023-10-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-3646812dbe1c40968faddbc02b4c8d7e2025-08-23T10:00:36ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532023-10-0119435035810.20996/1819-6446-2023-29342136Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closureD. V. Pevzner0N. S. Kostritca1I. A. Merkulova2O. B. Dorogun3A. L. Komarov4I. S. Yavelov5E.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyE.I. Chazov National Medical Research Center of CardiologyNational Medical Research Centre for Therapy and Preventive MedicineAim. To evaluate the long-term impact of endovascular left atrial appendage occlusion (LAAO) on heart failure (HF) course in patients with atrial fibrillation (AF).Materials and Methods: The prospective cohort study included patients with AF, HF, and a high risk of thromboembolic events, of which 39,6% underwent LAAO, 60,4% — received standard preventive therapy for cardioembolic events. Changes in BNP levels in the LAAO and control groups were analyzed throughout the observation period. The incidence of unfavorable HF outcomes (decompensated HF, hospitalizations related to HF, worsening HF class) was compared using the Cox-regression analysis with the log-rank test. A univariate analysis using Cox regression was conducted to identify independent predictors of endpoint achievement, involving all clinical and historical factors. Subsequently, a multivariate analysis was carried out, with predictors selected through the Wald exclusion test from those factors with a p-value less than 0.2 in the univariate analysis. Each factor was found to be a statistically significant independent predictor of the endpoint, with the overall model significance of p<0,001Results: s. The study included 139 patients (55 — LAAO group; 84 — control group) with a 3-year follow-up period. Most patients in the study had class I-III HF with preserved left ventricular ejection fraction (93,5%). In both groups, the level of BNP increased significantly over the observational period. Despite the initial differences between the groups, no differences were observed between the groups 1-3 years after the start of the study, which may indicate a tendency towards a lower growth rate of BNP in the LAAO group. The achievement rate of all endpoints was similar in both groups without significant differences. Multivariate analysis identified significant predictors of HF decompensation in the study cohort including left atrial volume, BNP levels, and HF class.Conclusion. Our study hasn’t shown any negative impact of endovascular LAAO on HF course in patients with AF. Additionally, several predictors of HF decompensation were identified in this patient cohort.https://www.rpcardio.online/jour/article/view/2934atrial fibrillationchronic heart failureleft atrial appendage occludecardioembolic events
spellingShingle D. V. Pevzner
N. S. Kostritca
I. A. Merkulova
O. B. Dorogun
A. L. Komarov
I. S. Yavelov
Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
Рациональная фармакотерапия в кардиологии
atrial fibrillation
chronic heart failure
left atrial appendage occlude
cardioembolic events
title Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
title_full Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
title_fullStr Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
title_full_unstemmed Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
title_short Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure
title_sort clinical features of heart failure in patients with atrial fibrillation the role of the endovascular left atrial appendage closure
topic atrial fibrillation
chronic heart failure
left atrial appendage occlude
cardioembolic events
url https://www.rpcardio.online/jour/article/view/2934
work_keys_str_mv AT dvpevzner clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure
AT nskostritca clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure
AT iamerkulova clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure
AT obdorogun clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure
AT alkomarov clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure
AT isyavelov clinicalfeaturesofheartfailureinpatientswithatrialfibrillationtheroleoftheendovascularleftatrialappendageclosure